Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 89357L501 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
CK Life Sciences Intl (Holdings) Inc
13D/A
|
83.9% |
8/3/2026
Event 8/3/2026
|
||
| Defj, LLC | 83.9% | |||
| CK Life Sciences Int'l., (Holdings) Inc. | 83.9% | |||
| Unleash Immuno Oncolytics, Inc. 13G | 9.9% |
7/28/2026
Event 7/23/2026
|
||
|
YA II PN, Ltd.
13G
|
9.9% |
4/20/2026
Event 4/15/2026
|
||
| YA II PN, Ltd. | 9.9% | |||
| YA Global Investments II (U.S.), LP | 9.9% | |||
| Yorkville Advisors Global, LP | 9.9% | |||
| Yorkville Advisors Global II, LLC | 9.9% | |||
| Yaii GP, LP | 9.9% | |||
| Yaii GP II, LLC | 9.9% | |||
| Mark Angelo | 9.9% | |||
| SC-Sigma Global Partners, LP | 9.9% | |||
| Elena Rosa Braci 13G | 6.2% |
7/28/2026
Event 7/23/2026
|
||
| Daniel Eduardo Katzman 13G | 5.2% |
7/28/2026
Event 7/23/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Sabby Management, LLC
13G/A
|
4.9% |
1/7/2026
Event 12/31/2025
|
||
| Sabby Management, LLC | 4.9% | |||
| Sabby Volatility Warrant Master Fund Ltd | 4.9% | |||
| Hal Mintz | 4.9% | |||
|
Goldman Sachs Group Inc
13G/A
|
0% |
11/10/2025
Event 9/30/2025
|
||
| The Goldman Sachs Group, Inc. | 0% | |||
| Goldman Sachs & Co. LLC | 0% | |||